NURECA LIMITED
NURECA · General/Diversified · NSE
₹234
Current Market Price
Fair Value (DCF)
₹108
Discount to FV
-53.6%
Updated just now
YieldIQ Score
40/100
Piotroski F-Score
6/9
Economic Moat
None
Confidence
35%
ROE
0.4%
Debt/Equity
0.03
WACC
11.1%
Market Cap
₹222.90 Cr
Quality & Valuation
Neutral model outputs — no recommendations.
ROCE
2.0%
Return on capital employed
EV / EBITDA
42.8×
Enterprise multiple
Debt / EBITDA
0.4×
Leverage vs earnings
Interest Coverage
4.4×
EBIT covers interest
Current Ratio
15.32×
Short-term liquidity
Asset Turnover
0.86×
Revenue per ₹ of assets
Revenue CAGR (3Y)
9.7%
3-year revenue growth
Revenue CAGR (5Y)
-7.3%
5-year revenue growth
DCF Scenario Analysis
vs CMP ₹233.6
Bear case
Margin of Safety —
Implied upside -216.9%
Base case
Margin of Safety —
Implied upside -115.4%
Bull case
Margin of Safety -128.6%
Implied upside -56.3%
Ratio Trends
NURECA · last 5 annual periods
ROE
0.4%
ROCE
2.0%
Operating Margin
—
Debt / Equity
0.03×
PE
29.0×
EV / EBITDA
20.7×
Historical Financials
NURECA · Annual, last 5 years· amounts in ₹Cr unless noted
| Metric | 2022 NSE_XBRL | 2023 NSE_XBRL | 2024 NSE_XBRL | 2025 yfinance | 2026 yfinance | CAGR |
|---|---|---|---|---|---|---|
| Revenue | ₹256 Cr | ₹111 Cr | ₹91.9 Cr | ₹110 Cr | ₹147 Cr | -12.9% |
| EBITDA | ₹62.9 Cr | ₹-8.0 Cr | ₹0.1 Cr | ₹4.9 Cr | ₹8.3 Cr | -39.8% |
| EBIT | ₹61.7 Cr | ₹-10.3 Cr | ₹-2.1 Cr | — | — | — |
| PAT | ₹45.0 Cr | ₹-8.3 Cr | ₹-1.8 Cr | ₹0.8 Cr | ₹2.1 Cr | -53.6% |
| EPS (diluted) | ₹44.96 | ₹-8.25 | ₹-1.79 | — | — | — |
| CFO | ₹1.4 Cr | ₹10.2 Cr | ₹-2.7 Cr | ₹-19.1 Cr | ₹3.3 Cr | +23.9% |
| CapEx | ₹-6.0 Cr | ₹-0.4 Cr | ₹-1.1 Cr | ₹-4.3 Cr | ₹-6.8 Cr | — |
| FCF | ₹-4.6 Cr | ₹9.8 Cr | ₹-3.8 Cr | ₹-23.4 Cr | ₹-3.5 Cr | — |
| Total Assets | ₹219 Cr | ₹207 Cr | ₹205 Cr | ₹210 Cr | ₹196 Cr | -2.7% |
| Total Debt | ₹4.4 Cr | ₹3.3 Cr | ₹2.5 Cr | ₹5.0 Cr | ₹2.3 Cr | -15.4% |
| Shareholders' Equity | ₹203 Cr | ₹195 Cr | ₹193 Cr | ₹194 Cr | ₹181 Cr | -2.9% |
CAGR computed across the visible window. Signs reverse if start value is zero or negative.
Peer Comparison
NURECA vs 1 closest peer by market-cap band
| Peer | MoS | Score | Verdict | ROE | PE |
|---|---|---|---|---|---|
UNIVPHOTO UNIVPHOTO | — | — | Pending | 10.0% | — |
Click a ticker to view its fair-value analysis.
Dividend History
2 ex-dividend events on file. Source: NSE corporate-actions feed.
Total paid (5Y)
₹5.00/sh
Last payout
2022-02-24
₹3.00
Peak payout
₹3.00
Trailing yield
—
Amounts parsed from NSE subject lines. Percent-of-face-value declarations are converted using the per-ticker face value (defaults to ₹10).
AI Analysis Summary
Model-generated description of metrics. Not investment advice. NURECA LIMITED (NURECA.NS) trades at 233.60 vs a model fair value of 108.46, a gap of -53.6%. Piotroski F-score: 6/9. Moat label: None. R...
Read full AI analysis →Reverse DCF
Market-implied growth
What FCF growth is priced in →
Risk Analysis
Volatility & drawdown
Risk profile of NURECA →
DuPont
ROE decomposition
Why ROE is what it is →
Technicals
RSI, MACD, MAs
Reference indicators →
News & Filings
Recent activity
BSE filings + news for NURECA →
Compare
Head-to-head with peers
Compare NURECA side by side →
Run Full Interactive Analysis
Interactive DCF sliders, sensitivity heatmap, peer comparison, and more.
Analyse NURECANow →Model estimates using publicly available data. Not investment advice. YieldIQ is not registered with SEBI as an investment adviser or research analyst. Past performance does not guarantee future results.